{
    "2021-05-31": [
        [
            {
                "time": "",
                "original_text": "通策医疗：宝群实业解除质押726万股",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "宝群实业",
                        "解除质押",
                        "726万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "通策医疗(600763.SH)：控股股东解押726万股",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "控股股东",
                        "解押",
                        "726万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药周报：骨修复材料市场增速近20% 人工材料为骨移植的新选择",
                "features": {
                    "keywords": [
                        "医药周报",
                        "骨修复材料",
                        "市场增速",
                        "人工材料",
                        "骨移植"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "骨修复材料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "八大券商主题策略：医药板块兼具科技加消费属性！未来3-5年是国产疫苗的黄金时代",
                "features": {
                    "keywords": [
                        "券商",
                        "主题策略",
                        "医药板块",
                        "科技加消费",
                        "国产疫苗",
                        "黄金时代"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}